Психиатрия и психофармакотерапия им. П.Б. Ганнушкина

Editor-in-Chief

Till 2022

Petr Viktorovich Morozov - Professor, Doctor of Medical Sciences, Professor of the Department of Psychiatry, Faculty of Further Professional Education, Russian National Research Medical University. N.I. Pirogova, Secretary General of the World Psychiatric Association, Ambassador of the European College of Neuropsychopharmacology in Russia, Member of the Board of the European Psychiatric Association, Vice President of the Russian Society of Psychiatrists (ROP), Editor-in-Chief of the Psychiatrist's Diary newspaper, member of the editorial boards of a number of domestic and foreign journals, author of more than 300 publications on topical issues of psychiatry, 10 monographs published in 9 languages ​​in Russia, USA, Great Britain, Switzerland and other countries. In 2014 he was awarded the Kraepelin-Alzheimer medal of the University of Munich "For scientific achievements and treatment of patients". Laureate of the national award "Harmony" for scientific, educational and teaching activities (2016)

From 2023

Denis Petrovich Morozov - A hereditary doctor in the 4th generation, in 1995 he graduated from the I.M. Sechenov Moscow Medical Academy, worked at the National Research Medical Center of the Russian Academy of Medical Sciences, studied internship and residency in psychiatry at the V.P. Serbsky State Scientific Center for Forensic and Social Psychiatry. He completed an internship at the Psychiatric Hospital of St. Anna (Paris, France). He is the author of a number of published articles and one book.

Е-mail: dmr@mentica-pvm.ru

Tel.: +7 (993) 908-00-26.

Editorial team

A.S. Avedisova - Dr. med. Sci., Prof., Head of the Department of New Means and Methods of Therapy, Federal State Budgetary Institution “Federal Medical Research Center named after A.I. V.P. Serbsky. E-mail: alla.avedisova@gmail.com

Yu.A.Aleksandrovsky - Corresponding Member RAS, Head of the Department of Borderline Psychiatric Pathology, Federal State Budgetary Institution Federal Medical Research Center named after A.I. V.P. Serbsky. E-mail: alexandrovsky_u@mail.ru

A.V. Andryushchenko - Dr. med. Sci., Professor of the Department of Psychiatry and Psychosomatics, IPO, SBEE HPE “First Moscow State Medical University named after I.I. I.M. Sechenov. E-mail: alissia.va@gmail.com

 I.P. Anokhina - Dr. med. Sci., Professor, Academician of the Russian Academy of Sciences, Head of the Department of Biomedical Problems of Narcology, Federal State Budgetary Institution “Federal Medical Research Center named after A.I. V.P. Serbsky. E-mail: iranokhina@mail.ru

A.E. Bobrov - Dr. med. Sci., Professor, Head of the Department of Remote Psychiatry and Psychotherapy of the Federal State Budgetary Institution "V.P. Serbsky National Medical Research Center of Psychiatry and Narcology" of the Ministry of Health of the Russian Federation

N.A. Bokhan - dir. FSBI "Research Institute of Mental Health", Academician. RAS, Dr. med. Sci., Professor of the Department of Psychotherapy and Psychological Counseling, Federal State Autonomous Educational Institution of Higher Education "NR TSU", Honored Worker of Science of the Russian Federation. E-mail: bokhan909@sibmail.com

D.S. Danilov - Dr. med. Sci., Head of the Department of Psychiatric Clinic named after S.S. Korsakov, SBEI HPE “First Moscow State Medical University. I.M. Sechenov”, danilov_d_s@staff.sechenov.ru

E.B. Dubnitskaya – Dr. med. Sci., Professor of the Department of Psychiatry and Psychosomatics, IPO, SBEE HPE “First Moscow State Medical University named after I.I. I.M. Sechenov”, Honored Worker of Science of the Russian Federation. E-mail: voronova_e@mail.ru

N.N. Ivanets - Dr. med. Sciences, Professor, Corresponding Member RAS, Professor of the Department of Psychiatry and Medical Psychology, SBEE HPE “First Moscow State Medical University named after I.I. I.M. Sechenov”, Honored Worker of Science of the Russian Federation. E-mail: kinkulkina@gmail.com M.V. Ivanov - Dr. med. Sci., Professor, Head of the Department of Biological Therapy of Mentally Ill FGBU “SPb NIPNI named after A.I. V.M. Bekhterev. E-mail: mivanov.spbgmu@gmail.com

S.V. Ivanov - Dr. med. Sci., Professor, Department of Psychiatry and Psychosomatics, Institute of Postgraduate Education, SBEE HPE “First Moscow State Medical University named after I.I. I.M. Sechenov. E-mail: stanislvi@gmail.com

B.A. Kazakovtsev - Dr. med. (Med.), Professor, Head of the Department of Forensic Psychiatric Prevention V.P. Serbsky. E-mail: b_kazakovtsev@ mail.ru

 V.V. Kalinin - Dr. med. Sci., Professor, Head of the Department of Exogenous Organic Disorders and Epilepsy, Federal State Budgetary Institution “MNIIP”. E-mail: doct.kalinin@mail.ru

M.A. Kinkulkina, Doctor of Medical Sciences, Professor, Head of the Department of Psychiatry and Medical Psychology, First Moscow State Medical University named after I.I. I.M. Sechenov, E-mail: kinkulkina@gmail.com

V.N. Krasnov - Dr. Sci., Professor, Head of the Department of Psychiatry, Federal State Professional Educational Institution of the Russian National Research Medical University. N.I. Pirogov. E-mail: krasnov@mtu-net.ru

E.G. Kostyukova – Ph.D. honey. Sci., Leading Researcher, Department of Therapy of Mental Illnesses V.P. Serbsky. E-mail: ekostukova@gmail.com

G.P. Kostyuk - Dr. med. Sci., Chief physician of the State Medical Institution "Psychiatric Clinical Hospital No. 1 named after N.A. Alekseev

 V.I. Krylov - Dr. med. Sci., Professor of the Department of Psychiatry and Narcology, SBEI HPE “First St. Petersburg State Medical University named after A.I. I.P. Pavlova. E-mail: info@1lmi-pto.spb.ru

V.E. Medvedev - Ph.D. honey. Sci., Head of the Department of Psychiatry and Medical Psychology, PFUR, E-mail: melkorcard@mail.ru

M.A. Morozova – Dr. med. Sci., Professor, Head of the Laboratory of Psychopharmacology, Federal State Budget Scientific Institution "NTsPZ". E-mail: m_morozova02@mail.ru

S.N. Mosolov - Dr. med. Sci., Professor, Head of the Department of Therapy of Mental Illnesses V.P. Serbsky ". E-mail: prof.mosolov@gmail.com

N.G. Neznanov - Dr. med. Sciences, Professor, Director of the Federal State Budgetary Institution “SPb NIPNI im. V.M. Bekhtereva, Chairman of the Board of the ROP, Chief Freelance Expert in Psychiatry of Roszdravnadzor, President of the World Association for Dynamic Psychiatry (WADP - World Association for Dynamic Psychiatry), Head of the Department of Psychiatry and Narcology with courses in Medical Psychology and Psychosomatic Medicine, SBEI HPE " First St. Petersburg State Medical University. I.P. Pavlova. E-mail: neznanov.spbgmu@gmail.com

 S.A. Ovsyannikov - Dr. med. Sci., Professor, Department of Psychiatry, Narcology and Psychotherapy, Faculty of Additional Professional Education, SBEE HPE “M. A.I. Evdokimova. E-mail: apavlichenko76@gmail.com

A.B. Smulevich - Dr. med. Sci., Professor, Head of the Department for the Study of Borderline Mental Pathology and Psychosomatic Disorders of the Federal State Budgetary Scientific Institution "NTSPZ", Head of the Department of Psychiatry and Psychosomatics of the Faculty of Postgraduate Vocational Education of the Moscow State Medical University. I.M. Sechenov”, Academician of the Russian Academy of Sciences, Honored Worker of Science of the Russian Federation. E-mail: voronova_e@mail.ru

G.M. Usov - Dr. med. Sci., Professor, Head of the Department of Psychiatry and Medical Psychology, Omsk State Medical University of the Ministry of Health of Russia, usovgm@gmail.com

A.B. Shmukler - Dr. med. Sci., Professor, Deputy Director of Federal State Budgetary Institution “FMICPN named after V.P. Serbsky”, ashmukler@yandex.ru

International Council

Chairman - A. Jablensky (Perth), MD sciences, professor.

S.A. Altynbekov (Alma-Ata) - Dr. med. sciences, professor.

T.I. Galako (Bishkek) - Dr. med. sciences, professor.

N.V. Izmailov (Baku) - Dr. med. sciences, professor.

N.A. Maruta (Kharkiv) - Dr. med. sciences, professor.

A.E. Melik-Pashayan (Yerevan) - Dr. med. sciences, professor.

O.A. Skugarevsky (Minsk) – Dr. med. sciences, professor.

Z.Sh.Ashurov (Tashkent) - Dr. med. sciences, professor.

G. Milavic (London) - Professor

C.Soldatos (Athens) - professor.

J.Sinzelle (Paris) - professor.

D. Moussoui (Casablanca) - professor.

H-J.Moeller (Munich) - professor.

J. Rybakowski (Poznan) - professor.

J.Chihai (Chisinau) - Professor

Guidelines for Authors

The journal “Psychiatry and Psychopharmacotherapy” publishes original articles and scientific reviews on relevant questions of medical science and practice, information about meetings, conferences and symposiums. 
Guidelines have been prepared according to requirements of High Attestation Commission (HAC) for periodicals included into the List of leading peer-reviewed scientific publications where basic scientific results of doctoral and master’s thesis should be published, with account for recommendations of Russian Science Citation Index (RSCI). 
For publication of an article, Author should provide materials and documents as follows: 
- referral from organization on letter-head with full and abbreviated name of organization (in Russian and English languages) with stamp and signature of the official having issued this document (1 copy); 
- manuscript (or scanned variant) of the article with signatures of all Authors; signing, each Author thereby transfers rights for publication of his/her article to Editorial Staff. E-variant of the article is sent to editorial office on electronic medium or by e-mail. Corresponding Author, his/her addresses (regular post and e-mail), phone numbers (office and mobile) should be indicated. 
Editorial Board of “Psychiatry and Psychopharmacotherapy” draws attention of Authors to necessity to observe the following rules during writing and design of articles for publication: 
1. Titles of articles should correspond to the following requirements: they should be informative; contain only conventional abbreviations; in translation of titles of the articles into English language there should not be transliterations from Russian language, beyond untranslatable proper names, devices and other objects having proper names; untranslatable slang known only by Russian-speaking specialists should not be used as well. This concerns also abstracts and key words. 
2. Family names of Authors of the articles in English language are provided in one of the accepted international systems of transliteration. 
3. Structure of the article must contain the following: 
- title of the article; 
- names of Authors; 
- name of institution where the work has been done; 
- abstract; 
- key words in Russian and English languages; 
- introduction (brief); 
- objective of investigation; 
- material and methods of investigation; 
- results of investigation and their discussion; 
- conclusions; 
- references. 
The following indications in titles of articles are not permitted: report 1, 2 etc., part 1, 2 etc. 
4. Table must contain only necessary data and represent summarized and statistically processed materials. Each table is provided with title and inserted into text after paragraph with the first reference to it. 
5. Amount of graphical material should be minimum (not more than 3 figures). Each figure should have title (under the figure) that explains all its elements. For construction of graphics and diagrams Microsoft Office Excel should be used. Each figure is inserted into text as an object of Microsoft Office Excel. 
6. References in text should be provided in square brackets according to numeration in list of references. List of references for original article should contain not less than 5 and not more than 25 references. For scientific review and summarizing articles there should not be more than 60 references. List of references is composed in alphabetical order – firstly native, then foreign Authors. 
List of references is provided in 2 variants: 
1) according to State Standard R 7.0.5-2008 (Russian variant together with foreign references); 
2) variant in Roman alphabet repeating list of references to Russian part, irrespective of whether there are or there are not foreign references in it. 
7. Size of the article (Microsoft Office Word in one file) must not exceed 10 pages of format А4 (font 12 points Times New Roman, 1,5-spaced, margins: left, right, top, bottom – 2 cm), including tables, schemata, figures and references. 
Providing the article, indices of the article (UDC, LBC) should be indicated according to tables of the Universal Decimal Classification and Library-Bibliographic Classification available at libraries of medical (not general) profile. 
The article should be submitted with abstract in Russian and English languages containing 100–250 words (according to State Standard 7.9-95 – 850 characters, not less than 10 lines) with summary of subject of the article and basic available in it results. Abstract in English language must in the beginning of the text contain title of the article, initials and names of Authors. 
Presence of key words in Russian and English languages is necessary. 
Indication of affiliations of all Authors (with full names), their positions and contact information is obligatory. 
Editorial Staff reserves the right of reduction and editing of the articles. 
The journal is issued at the expense of subscribers and sponsors. 
Publication fee from postgraduate students (the only Author) is not taken. Postgraduate status must be certified by Head of institution. Original of certificate with stamp of the institution should be sent by regular post to editorial office. 
Submitting text of the paper for publication in the journal, Author guarantees correctness of all information about him/her, absence of plagiarism and other forms of improper borrowing in the manuscript of work, proper design of all borrowings of text, tables, schemata, and illustrations. Authors of published materials are responsible for selection and accuracy of introduced facts, citations, statistical data and other information. 
Editorial Staff is not responsible for authenticity of information introduced by Authors. The Author submitting the manuscript, takes personal responsibility for originality of the investigation, entrusts the Editorial Staff to promulgate his/her work through its publication in press. 
Deliberate misappropriation of the Authorship of work of science, thoughts, arts or invention belonging to somebody else is regarded as plagiarism. Plagiarism can be violation of Author-legal legislation and patent legislation and as such can entail juridical responsibility of the Author. The Author guarantees availability in him/her exclusive rights on use of material submitted to Editorial Staff. In case of violation of this guarantee and presentation of claims to Editorial Staff in this association, Author is obliged to settle all claims independently and at his/her expense. Editorial Staff is not responsible to third parties for violation of the guarantees given by the Author. 
Editorial Staff reserves the right to refer articles for additional reviewing. In this case, terms of publication are delayed. Materials of additional expertise are presented to the Author. 
Submission of materials to Editorial Staff for publication means that the Author agrees the above requirements. 

Articles should be referred to editorial office: 117437, Russian Federation, Мoscow, Ostrovityanova st., 9-4-249. 
E-mail: dmr@mentica-pvm.ru
Tel. for inquiries: +7 (916)676-31-80. 
Fax: +7 (993) 908-00-26.

Focus and Scope

The aim of " Psychiatry and psychopharmacotherapy " journal is postgraduate educationand provision of high professional level of specialists in the presence of rapid development of biotechnology and medical science.

Journal " Psychiatry and psychopharmacotherapy " is not only aimed to give coverage to the theoretical information, but toupdate the knowledge base and practitioners skills, i.e. to participate in continuing education. The main goals are to eliminate the defects of basic professional skills, to expand and make corrections about theoretical knowledge and to help specialists in overcoming professional stereotypes and to avoid common mistakes in medical practice. Another aim of the magazine is to develop theoretical knowledge of the pathogenesis, clinical manifestations and treatment of co-morbid disorders, which can be found in the practice of physicians in any specialty.

Publication Frequency

6 issues per year

Peer-Review

A double-blind peer review method is mandatory for processing of all scientific manuscripts submitted to the editorial stuff of " Psychiatry and psychopharmacotherapy ". This implies that neither the reviewer is aware of the authorship of the manuscript, nor the author maintains any contact with the reviewer.

1. Members of the editorial board and leading Russian and international experts in corresponding areas of life sciences, invited as independent readers, perform peer reviews. Editor-in-chief, deputy editor-in-chief or science editor choose readers for peer review. We aim to limit the review process to 2-4 weeks, though in some cases the schedule may be adjusted at the reviewer’s request.
2. Reviewer has an option to abnegate the assessment should any conflict of interests arise that may affect perception or interpretation of the manuscript. Upon the scrutiny, the reviewer is expected to present the editorial board with one of the following recommendations:
   - to accept the paper in its present state;
   - to invited the author to revise their manuscript to address specific concerns before final decision is reached;
   - that final decision be reached following further reviewing by another specialist;
   - to reject the manuscript outright.
3. If the reviewer has recommended any refinements, the editorial staff would suggest the author either to implement the corrections, or to dispute them reasonably. Authors are kindly required to limit their revision to 2 months and resubmit the adapted manuscript within this period for final evaluation.
4. We politely request that the editor be notified verbally or in writing should the author decide to refuse from publishing the manuscript. In case the author fails to do so within 3 months since receiving a copy of the initial review, the editorial board takes the manuscript off the register and notifies the author accordingly.
5. If author and reviewers meet insoluble contradictions regarding revision of the manuscript, the editor-in-chief resolves the conflict by his own authority.
6. The editorial board reaches final decision to reject a manuscript on the hearing according to reviewers’ recommendations, and duly notifies the authors of their decision via e-mail. The board does not accept previously rejected manuscripts for re-evaluation.
7. Upon the decision to accept the manuscript for publishing, the editorial staff notifies the authors of the scheduled date of publication.
8. Kindly note that positive review does not guarantee the acceptance, as final decision in all cases lies with the editorial board. By his authority, editor-in-chief rules final solution of every conflict.
9. Original reviews of submitted manuscripts remain deposited for 5 years.
10. The editorial office sends copies of reviews to the Ministry of education and science of the Russian Federation in the event of receipt of request

Publishing Ethics

The section is prepared according to the files (http://health.elsevier.ru/attachments/editor/file/ethical_code_final.pdf) of Elsevier publisher (https://www.elsevier.com/) and files (http://publicationethics.org/resources) from Committee on Publication Ethics (COPE - http://publicationethics.org/).

1. Introduction

1.1. The publication in a peer reviewed learned journal, serves many purposes outside of simple communication. It is a building block in the development of a coherent and respected network of knowledge. For all these reasons and more it is important to lay down standards of expected ethical behaviour by all parties involved in the act of publishing: the author, the journal editor, the peer reviewer, the publisher and the society for society-owned or sponsored journal: "Psychiatry and psychopharmacotherapy "

1.2.Publisher has a supporting, investing and nurturing role in the scholarly communication process but is also ultimately responsible for ensuring that best practice is followed in its publications.

1.3. Publisher takes its duties of guardianship over the scholarly record extremely seriously. Our journal programmes record «the minutes of science» and we recognise our responsibilities as the keeper of those «minutes» in all our policies not least the ethical guidelines that we have here adopted.

2. Duties of Editors

2.1.Publication decision – The Editor of a learned " Psychiatry and psychopharmacotherapy " is solely and independently responsible for deciding which of the articles submitted to the journal should be published, often working on conjunction with the relevant society (for society-owned or sponsored journals). The validation of the work in question and its importance to researchers and readers must always underwrite such decisions. The Editor may be guided by the policies of the " Psychiatry and psychopharmacotherapy " journal’s editorial board and constrained by such legal requirements as shall then be in force regarding libel, copyright infringement and plagiarism. The editor may confer with other editors or reviewers (or society officers) in making this decision.

2.2.Fair play – An editor should evaluate manuscripts for their intellectual content without regard to race, gender, sexual orientation, religious belief, ethnic origin, citizenship, or political philosophy of the authors.

2.3.Confidentiality – The editor and any editorial staff of " Psychiatry and psychopharmacotherapy " must not disclose any information about a submitted manuscript to anyone other than the corresponding author, reviewers, potential reviewers, other editorial advisers, and the publisher, as appropriate.

2.4.Disclosure and Conflicts of interest

2.4.1. Unpublished materials disclosed in a submitted manuscript must not be used in an editor’s own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.

2.4.2. Editors should recuse themselves (i.e. should ask a co-editor, associate editor or other member of the editorial board instead to review and consider) from considering manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or (possibly) institutions connected to the papers.

2.5.Vigilance over published record – An editor presented with convincing evidence that the substance or conclusions of a published paper are erroneous should coordinate with the publisher (and/or society) to promote the prompt publication of a correction, retraction, expression of concern, or other note, as may be relevant.

2.6.Involvement and cooperation in investigations – An editor should take reasonably responsive measures when ethical complaints have been presented concerning a submitted manuscript or published paper, in conjunction with the publisher (or society). Such measures will generally include contacting the author of the manuscript or paper and giving due consideration of the respective complaint or claims made, but may also include further communications to the relevant institutions and research bodies.

3. Duties of Reviewers

3.1.Contribution to Editorial Decisions – Peer review assists the editor in making editorial decisions and through the editorial communications with the author may also assist the author in improving the paper. Peer review is an essential component of formal scholarly communication, and lies at the heart of the scientific method. Publisher shares the view of many that all scholars who wish to contribute to publications have an obligation to do a fair share of reviewing.

3.2.Promptness – Any selected referee who feels unqualified to review the research reported in a manuscript or knows that its prompt review will be impossible should notify the editor of "Psychiatry and psychopharmacotherapy " and excuse himself from the review process.

3.3.Confidentiality – Any manuscripts received for review must be treated as confidential documents. They must not be shown to or discussed with others except as authorised by the editor.

3.4.Standard and objectivity – Reviews should be conducted objectively. Personal criticism of the author is inappropriate. Referees should express their views clearly with supporting arguments.

3.5.Acknowledgement of Sources – Reviewers should identify relevant published work that has not been cited by the authors. Any statement that an observation, derivation, or argument had been previously reported should be accompanied by the relevant citation. A reviewer should also call to the editor’s attention any substantial similarity or overlap between the manuscript under consideration and any other published paper of which they have personal knowledge.

3.6.Disclosure and Conflict of Interest

3.6.1.Unpublished materials disclosed in a submitted manuscript must not be used in a reviewer’s own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.

3.6.2. Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

4. Duties of Authors

4.1.Reporting standards

4.1.1. Authors of reports of original research should present an accurate account of the work performed as well as an objective discussion of its significance. Underlying data should be represented accurately in the paper. A paper should contain sufficient detail and references to permit others to replicate the work. Fraudulent or knowingly inaccurate statements constitute unethical behaviour and are unacceptable.

4.1.2. Review and professional publication articles should also be accurate and objective, and editorial 'opinion’ works should be clearly identified as such.

4.2.Data Access and Retention – Authors may be asked to provide the raw data in connection with a paper for editorial review, and should be prepared to provide public access to such data (consistent with the ALPSP-STM Statement on Data and Databases), if practicable, and should in any event be prepared to retain such data for a reasonable time after publication.

4.3.Originality and Plagiarism

4.3.1. The authors should ensure that they have written entirely original works, and if the authors have used the work and/or words of others, this has been appropriately cited or quoted.

4.3.2. Plagiarism takes many forms, from ‘passing off’ another’s paper as the author’s own paper, to copying or paraphrasing substantial parts of another’s paper (without attribution), to claiming results from research conducted by others. Plagiarism in all its forms constitutes unethical publishing behaviour and is unacceptable.

4.4.Multiple, Redundant or Concurrent Publication

4.4.1. An author should not in general publish manuscripts describing essentially the same research in more than one journal of primary publication. Submitting the same manuscript to more than one journal concurrently constitutes unethical publishing behaviour and is unacceptable.

4.4.2. In general, an author should not submit for consideration in another journal a previously published paper.

4.4.3. Publication of some kinds of articles (eg, clinical guidelines, translations) in more than one journal is sometimes justifiable, provided certain conditions are met. The authors and editors of the journals concerned must agree to the secondary publication, which must reflect the same data and interpretation of the primary document. The primary reference must be cited in the secondary publication. Further detail on acceptable forms of secondary publication can be found at www.icmje.org.

4.5.Acknowledgement of Sources – Proper acknowledgment of the work of others must always be given. Authors should cite publications that have been influential in determining the nature of the reported work. Information obtained privately, as in conversation, correspondence, or discussion with third parties, must not be used or reported without explicit, written permission from the source. Information obtained in the course of confidential services, such as refereeing manuscripts or grant applications, must not be used without the explicit written permission of the author of the work involved in these services.

4.6.Authorship of the Paper

4.6.1. Authorship should be limited to those who have made a significant contribution to the conception, design, execution, or interpretation of the reported study. All those who have made significant contributions should be listed as co-authors. Where there are others who have participated in certain substantive aspects of the research project, they should be acknowledged or listed as contributors.

4.6.2. The corresponding author should ensure that all appropriate co-authors and no inappropriate co-authors are included on the paper, and that all co-authors have seen and approved the final version of the paper and have agreed to its submission for publication.

4.7.Hazards and Human or Animal Subjects

4.7.1. If the work involves chemicals, procedures or equipment that have any unusual hazards inherent in their use, the author must clearly identify these in the manuscript.

4.7.2. If the work involves the use of animal or human subjects, the author should ensure that the manuscript contains a statement that all procedures were performed in compliance with relevant laws and institutional guidelines and that the appropriate institutional committee(s) have approved them. Authors should include a statement in the manuscript that informed consent was obtained for experimentation with human subjects. The privacy rights of human subjects must always be observed.

4.8. Disclosure and Conflicts of Interest

4.8.1. All authors should disclose in their manuscript any financial or other substantive conflict of interest that might be construed to influence the results or interpretation of their manuscript. All sources of financial support for the project should be disclosed.

4.8.2. Examples of potential conflicts of interest which should be disclosed include employment, consultancies, stock ownership, honoraria, paid expert testimony, patent applications/registrations, and grants or other funding. Potential conflicts of interest should be disclosed at the earliest possible stage.

4.9. Fundamental errors in published works – When an author discovers a significant error or inaccuracy in a published work, it is the author’s obligation to promptly notify the editor of "Psychiatry and psychopharmacotherapy " journal and cooperate with Publisher to retract or correct the paper, If the editor or the publisher learn from a third party that a published work contains a significant error, it is the obligation of the author to promptly retract or correct the paper.

5. Duties of the Publisher (and if relevant, Society)

5.1. Publisher should adopt policies and procedures that support editors, reviewers and authors of " Psychiatry and psychopharmacotherapy " in performing their ethical duties under these ethics guidelines. The publisher should ensure that the potential for advertising or reprint revenue has no impact or influence on editorial decisions.

5.2. The publisher should support " Psychiatry and psychopharmacotherapy " journal editors in the review of complaints raised concerning ethical issues and help communications with other journals and/or publishers where this is useful to editors.

5.3. Publisher should develop codes of practice and inculcate industry standards for best practice on ethical matters, errors and retractions.

5.4. Publisher should provide specialised legal review and counsel if necessary.

Author fees

Publication in journal is free of charge for all the authors.

Disclosure and Conflict of Interest

Unpublished materials disclosed in a submitted manuscript must not be used in a reviewer’s own research without the express written consent of the author. Privileged information or ideas obtained through peer review must be kept confidential and not used for personal advantage.

Reviewers should not consider manuscripts in which they have conflicts of interest resulting from competitive, collaborative, or other relationships or connections with any of the authors, companies, or institutions connected to the papers.

The journal has been published by Autonomous non-profit organization "Scientific and Practical Center "Psychea" named after Pyotr Viktorovich Morozov" (till 2022 by IP Morozov PV since 2010 (in cooperation with MMA "MediaMedica").

Currently, cooperation continues - the electronic version of the journal is located on the website of MMA "MediaMedica" www.con-med.ru

The journal "Psychiatry and psychopharmacotherapy" is a publication of the Russian Society of Psychiatrists (ROP).

Editorial address: 117437, Russian Federation, Мoscow, Ostrovityanova st., 9-4-249. 

Publisher's phone: +7 (993) 908-00-26.

E-mail: dmr@mentica-pvm.ru